Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Transplant Diabetes”

118 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 118 results

Testing effectiveness (Phase 2)Study completedNCT00888628
What this trial is testing

Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients

Who this might be right for
Diabetes Mellitus, Type I
Massachusetts General Hospital 7
Not applicableStudy completedNCT03869281
What this trial is testing

Fracture Risk After Pancreas Transplantation (FraPaT)

Who this might be right for
Diabetes Mellitus, Type 1Fractures, Bone
Università Vita-Salute San Raffaele 81
Not applicableNot Yet RecruitingNCT02558452
What this trial is testing

European Transplant Registry of Senior Renal Transplant Recipients on Advagraf

Who this might be right for
Graft FailureDeathAcute Rejection of Renal Transplant+7 more
Klemens Budde 1,000
Not applicableEnded earlyNCT03785236
What this trial is testing

Visualizing Beta Cells After Islet Transplantation

Who this might be right for
Type 1 Diabetes Mellitus
Radboud University Medical Center 13
Post-approval studies (Phase 4)Study completedNCT03157414
What this trial is testing

Empagliflozin in Renal Transplant Recipients

Who this might be right for
Diabetes MellitusRenal InsufficiencySafety Issues
Oslo University Hospital 49
Testing effectiveness (Phase 2)Ended earlyNCT01206101
What this trial is testing

Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 3
Post-approval studies (Phase 4)Study completedNCT04496401
What this trial is testing

PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus

Who this might be right for
Kidney TransplantationPancreas TransplantationDiabetes
Nantes University Hospital 25
Post-approval studies (Phase 4)Study completedNCT01092806
What this trial is testing

Insulin Secretion and Advagraf

Who this might be right for
Post Transplant Diabetes Mellitus
University of Oslo School of Pharmacy 20
Post-approval studies (Phase 4)UnknownNCT01875224
What this trial is testing

Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression

Who this might be right for
New Onset Diabetes After TransplantKidney Transplantation
University of Arizona 32
Post-approval studies (Phase 4)Ended earlyNCT00936663
What this trial is testing

Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation

Who this might be right for
Type 2 DiabetesEnd Stage Renal Disease
University of Nebraska 3
Testing effectiveness (Phase 2)Study completedNCT03961256
What this trial is testing

Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation

Who this might be right for
Pre Diabetes
Mayo Clinic 9
Testing effectiveness (Phase 2)Study completedNCT03113110
What this trial is testing

Empagliflozin in Post-Transplantation Diabetes Mellitus

Who this might be right for
Posttransplant Diabetes Mellitus
Medical University of Vienna 16
Testing effectiveness (Phase 2)Study completedNCT03304626
What this trial is testing

Budesonide for Liver Transplant Immune Suppression

Who this might be right for
Acute Cellular Graft RejectionNew Onset Diabetes After Transplant
University of Cincinnati 40
Not applicableStudy completedNCT02591849
What this trial is testing

GLP-1 Effects on Insulin and Glucagon in PTDM

Who this might be right for
Post-transplant Diabetes Mellitus
Oslo University Hospital 24
Not applicableStudy completedNCT00172536
What this trial is testing

Effects of Exercise Training on Left Ventricular Function in Type 2 Diabetic Patients Post Coronary Artery Bypass Graft

Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentCoronary ArteriosclerosisPost Coronary Artery Bypass Grafting
National Taiwan University Hospital 65
Post-approval studies (Phase 4)Study completedNCT00171717
What this trial is testing

Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant

Who this might be right for
Maintenance Liver Transplant Patients With New Onset Diabetes
Novartis 39
Not applicableLooking for participantsNCT02038517
What this trial is testing

Cirrhosis, Effects of TRAnsplantation and Diabetes

Who this might be right for
Liver Cirrhosis
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 200
Not applicableNot Yet RecruitingNCT06704542
What this trial is testing

Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONDiabetes MellitusImpaired Fasting Glucose
Ruijin Hospital 1,000
Not applicableUnknownNCT01537445
What this trial is testing

MR-Evaluation of Renal Function-After-Pancreas-transplantation

Who this might be right for
DiabetesRenal FailurePancreas Transplantation
Uppsala University 40
Not applicableWithdrawnNCT00834496
What this trial is testing

Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation

Who this might be right for
Side Effects of Calcineurin InhibitorsRenal ToxicityHepatic Fibrosis on Biopsy+2 more
Thomas Jefferson University
Load More Results